|
C21ORF91 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.375300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.193800E-02 |
| Normal-vs-Stage2 |
1.164240E-04 |
| Normal-vs-Stage3 |
7.503900E-03 |
| Normal-vs-Stage4 |
1.736040E-03 |
| Stage1-vs-Stage2 |
5.078900E-03 |
| Stage1-vs-Stage3 |
2.722400E-01 |
| Stage1-vs-Stage4 |
9.466100E-02 |
| Stage2-vs-Stage3 |
7.694000E-02 |
| Stage2-vs-Stage4 |
1.560360E-01 |
| Stage3-vs-Stage4 |
6.324000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.277570E-02 |
| Normal-vs-AfricanAmerican |
2.972500E-02 |
| Normal-vs-Asian |
1.664400E-01 |
| Caucasian-vs-AfricanAmerican |
4.771000E-01 |
| Caucasian-vs-Asian |
6.516600E-01 |
| AfricanAmerican-vs-Asian |
3.511000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.787100E-04 |
| Normal-vs-Female |
8.584300E-03 |
| Male-vs-Female |
1.300840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.612200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.163800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.970600E-04 |
| Normal-vs-Age(81-100Yrs) |
8.427600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.207180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.450350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.604400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.297800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.146800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.310000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.847400E-01 |
| Classical-VS-Follicular |
3.33066907387547E-16 |
| Classical-VS-Other |
1.192220E-01 |
| Classical-VS-Normal |
2.915600E-01 |
| Tall-VS-Follicular |
2.18439999999376E-06 |
| Tall-VS-Other |
1.943560E-01 |
| Tall-VS-Normal |
2.834800E-01 |
| Follicular-VS-Other |
2.572800E-01 |
| Follicular-VS-Normal |
5.21505061357175E-12 |
| Other-VS-Normal |
2.953900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.42269999999723E-05 |
| Normal-vs-N1 |
1.952250E-02 |
| N0-vs-N1 |
2.318600E-01 |
|
|
